Melt Pharmaceuticals Improves Patent Estate for Sublingual Non-Opioid Pain and Sedation Formulations
February 13, 2019 07:00 ET
|
Harrow Health, Inc.; Melt Pharmaceuticals
SAN DIEGO and BOSTON, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Melt Pharmaceuticals, Inc., a specialty pharmaceutical company recently deconsolidated from Harrow Health, Inc. (NASDAQ: HROW), today...
Harrow Health Announces $11 Million Series A Financing for Melt Pharmaceuticals Subsidiary
February 05, 2019 07:00 ET
|
Harrow Health, Inc.; Melt Pharmaceuticals, Inc.
SAN DIEGO and BOSTON, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Melt Pharmaceuticals, Inc., an affiliated company of Harrow Health, Inc. (NASDAQ: HROW), today announced it has entered into definitive stock...